{"id":14225,"date":"2021-06-28T12:20:15","date_gmt":"2021-06-28T11:20:15","guid":{"rendered":"https:\/\/ppr-antibioresistance.inserm.fr\/?p=14225"},"modified":"2021-06-28T14:57:37","modified_gmt":"2021-06-28T13:57:37","slug":"conference-online-antibioresistance-mecanismes-et-innovation-therapeutique-12-et-13-juillet-2021","status":"publish","type":"post","link":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/conference-online-antibioresistance-mecanismes-et-innovation-therapeutique-12-et-13-juillet-2021\/","title":{"rendered":"Conf\u00e9rence online : “Antibior\u00e9sistance : m\u00e9canismes et innovation th\u00e9rapeutique”, 12 et 13 juillet 2021"},"content":{"rendered":"\n

ANTIBIOR\u00c9SISTANCE – M\u00c9CANISMES ET INNOVATION TH\u00c9RAPEUTIQUE<\/strong><\/p>\n\n\n\n

La d\u00e9couverte des antibiotiques au cours du XXe<\/sup> si\u00e8cle a r\u00e9volutionn\u00e9 le traitement et l\u2019impact des infections bact\u00e9riennes. Cependant, leur usage intensif \u2013 en sant\u00e9 humaine et v\u00e9t\u00e9rinaire ainsi que leur diss\u00e9mination dans l\u2019environnement \u2013 conduisent \u00e0 l\u2019apparition et la diffusion rapide de r\u00e9sistances. <\/p>\n\n\n\n

Cela nous oblige \u00e0 penser globalement de nouvelles strat\u00e9gies, \u00e0 la fois de d\u00e9couverte de nouveaux agents antibact\u00e9riens, de gestion de l\u2019utilisation de ces agents, de lutte contre les r\u00e9sistances via<\/em> la caract\u00e9risation de leurs m\u00e9canismes ou le d\u00e9veloppement d’approches alternatives dans la lutte contre ces pathog\u00e8nes.<\/p>\n\n\n\n

Cette conf\u00e9rence<\/a> sera l\u2019occasion d\u2019illustrer ces aspects et les challenges \u00e0 relever pour le\u00a0d\u00e9veloppement\u00a0d\u2019approches th\u00e9rapeutiques innovantes.<\/p>\n\n\n\n

ORATEURS INVIT\u00c9S<\/strong><\/p>\n\n\n\n

Priscilla Brodin – Institut Pasteur Lille, Lille<\/p>\n\n\n\n

Vincent Cattoir – CHU de Rennes, Rennes<\/p>\n\n\n\n

Christophe Dagot – Universit\u00e9 de Limoges, Limoges<\/p>\n\n\n\n

Andrea Dessen – IBS, Grenoble<\/p>\n\n\n\n

Victor Duarte – LCBM, Grenoble<\/p>\n\n\n\n

Philippe Glaser – Institut Pasteur, Paris<\/p>\n\n\n\n

Ruben Hartkoorn –  Centre d’infection et d’immunit\u00e9 de Lille, Lille<\/p>\n\n\n\n

Evelyne Jouvin-Marche – Aviesan, Grenoble<\/p>\n\n\n\n

Rupa Kanapathipillai – M\u00e9decins sans fronti\u00e8res (MSF) – \u00e0 confirme<\/em>r<\/p>\n\n\n\n

Christian Lesterlin – IBCP, Lyon<\/p>\n\n\n\n

Jean-Yves Madec – ANSES, Paris<\/p>\n\n\n\n

Claudine M\u00e9digue – CNRS, Paris<\/p>\n\n\n\n

Matthew Wook Chang – Universit\u00e9 de Singapour, Singapour<\/p>\n\n\n\n

Comit\u00e9 scientifique :<\/strong><\/p>\n\n\n\n

Agn\u00e8s Delmas (CNRS), Jean-Luc Galzi (CNRS), Carine Giovannangeli (Aviesan), Boris Vauzeilles (CNRS)<\/p>\n\n\n\n

Acc\u00e9der au programme via ce lien<\/a>.<\/p>\n\n\n\n

Inscription \u00e0 l’\u00e9v\u00e8nement via ce formulaire<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"

ANTIBIOR\u00c9SISTANCE – M\u00c9CANISMES ET INNOVATION TH\u00c9RAPEUTIQUE La d\u00e9couverte des antibiotiques au cours du XXe si\u00e8cle a r\u00e9volutionn\u00e9 le traitement et l\u2019impact des infections bact\u00e9riennes. Cependant, leur usage intensif \u2013 en sant\u00e9 humaine et v\u00e9t\u00e9rinaire ainsi que leur diss\u00e9mination dans l\u2019environnement \u2013 conduisent \u00e0 l\u2019apparition et la diffusion rapide de r\u00e9sistances. Cela nous oblige \u00e0 penser globalement […]<\/p>\n","protected":false},"author":139,"featured_media":14255,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[31,35],"tags":[],"acf":[],"yoast_head":"\nConf\u00e9rence online : "Antibior\u00e9sistance : m\u00e9canismes et innovation th\u00e9rapeutique", 12 et 13 juillet 2021 - Interface nationale ANTIBIOR\u00c9SISTANCE<\/title>\n<meta name=\"description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/conference-online-antibioresistance-mecanismes-et-innovation-therapeutique-12-et-13-juillet-2021\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Conf\u00e9rence online : "Antibior\u00e9sistance : m\u00e9canismes et innovation th\u00e9rapeutique", 12 et 13 juillet 2021 - Interface nationale ANTIBIOR\u00c9SISTANCE\" \/>\n<meta property=\"og:description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/conference-online-antibioresistance-mecanismes-et-innovation-therapeutique-12-et-13-juillet-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Interface nationale ANTIBIOR\u00c9SISTANCE\" \/>\n<meta property=\"article:published_time\" content=\"2021-06-28T11:20:15+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-06-28T13:57:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/06\/Webconf-antibios3.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"748\" \/>\n\t<meta property=\"og:image:height\" content=\"345\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"\u00c9milie Noguez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"\u00c9milie Noguez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/conference-online-antibioresistance-mecanismes-et-innovation-therapeutique-12-et-13-juillet-2021\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/conference-online-antibioresistance-mecanismes-et-innovation-therapeutique-12-et-13-juillet-2021\/\"},\"author\":{\"name\":\"\u00c9milie Noguez\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3\"},\"headline\":\"Conf\u00e9rence online : “Antibior\u00e9sistance : m\u00e9canismes et innovation th\u00e9rapeutique”, 12 et 13 juillet 2021\",\"datePublished\":\"2021-06-28T11:20:15+00:00\",\"dateModified\":\"2021-06-28T13:57:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/conference-online-antibioresistance-mecanismes-et-innovation-therapeutique-12-et-13-juillet-2021\/\"},\"wordCount\":276,\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/conference-online-antibioresistance-mecanismes-et-innovation-therapeutique-12-et-13-juillet-2021\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/06\/Webconf-antibios3.jpg\",\"articleSection\":[\"Actualit\u00e9s\",\"Ev\u00e8nements & Colloques\"],\"inLanguage\":\"fr-FR\"},{\"@type\":[\"WebPage\",\"ItemPage\"],\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/conference-online-antibioresistance-mecanismes-et-innovation-therapeutique-12-et-13-juillet-2021\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/conference-online-antibioresistance-mecanismes-et-innovation-therapeutique-12-et-13-juillet-2021\/\",\"name\":\"Conf\u00e9rence online : \\\"Antibior\u00e9sistance : m\u00e9canismes et innovation th\u00e9rapeutique\\\", 12 et 13 juillet 2021 - Interface nationale ANTIBIOR\u00c9SISTANCE\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/conference-online-antibioresistance-mecanismes-et-innovation-therapeutique-12-et-13-juillet-2021\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/conference-online-antibioresistance-mecanismes-et-innovation-therapeutique-12-et-13-juillet-2021\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/06\/Webconf-antibios3.jpg\",\"datePublished\":\"2021-06-28T11:20:15+00:00\",\"dateModified\":\"2021-06-28T13:57:37+00:00\",\"description\":\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\",\"breadcrumb\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/conference-online-antibioresistance-mecanismes-et-innovation-therapeutique-12-et-13-juillet-2021\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/conference-online-antibioresistance-mecanismes-et-innovation-therapeutique-12-et-13-juillet-2021\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/conference-online-antibioresistance-mecanismes-et-innovation-therapeutique-12-et-13-juillet-2021\/#primaryimage\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/06\/Webconf-antibios3.jpg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/06\/Webconf-antibios3.jpg\",\"width\":748,\"height\":345,\"caption\":\"Cr\u00e9dit : Aviesan\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/conference-online-antibioresistance-mecanismes-et-innovation-therapeutique-12-et-13-juillet-2021\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Infos pratiques & communications\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Actualit\u00e9s\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Conf\u00e9rence online : “Antibior\u00e9sistance : m\u00e9canismes et innovation th\u00e9rapeutique”, 12 et 13 juillet 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\",\"name\":\"Interface nationale ANTIBIOR\u00c9SISTANCE\",\"description\":\"PPR Antibior\u00e9sistance - Inserm\",\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\",\"name\":\"Inserm\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"width\":1,\"height\":1,\"caption\":\"Inserm\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3\",\"name\":\"\u00c9milie Noguez\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Conf\u00e9rence online : \"Antibior\u00e9sistance : m\u00e9canismes et innovation th\u00e9rapeutique\", 12 et 13 juillet 2021 - Interface nationale ANTIBIOR\u00c9SISTANCE","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/conference-online-antibioresistance-mecanismes-et-innovation-therapeutique-12-et-13-juillet-2021\/","og_locale":"fr_FR","og_type":"article","og_title":"Conf\u00e9rence online : \"Antibior\u00e9sistance : m\u00e9canismes et innovation th\u00e9rapeutique\", 12 et 13 juillet 2021 - Interface nationale ANTIBIOR\u00c9SISTANCE","og_description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","og_url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/conference-online-antibioresistance-mecanismes-et-innovation-therapeutique-12-et-13-juillet-2021\/","og_site_name":"Interface nationale ANTIBIOR\u00c9SISTANCE","article_published_time":"2021-06-28T11:20:15+00:00","article_modified_time":"2021-06-28T13:57:37+00:00","og_image":[{"width":748,"height":345,"url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/06\/Webconf-antibios3.jpg","type":"image\/jpeg"}],"author":"\u00c9milie Noguez","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"\u00c9milie Noguez","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/conference-online-antibioresistance-mecanismes-et-innovation-therapeutique-12-et-13-juillet-2021\/#article","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/conference-online-antibioresistance-mecanismes-et-innovation-therapeutique-12-et-13-juillet-2021\/"},"author":{"name":"\u00c9milie Noguez","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3"},"headline":"Conf\u00e9rence online : “Antibior\u00e9sistance : m\u00e9canismes et innovation th\u00e9rapeutique”, 12 et 13 juillet 2021","datePublished":"2021-06-28T11:20:15+00:00","dateModified":"2021-06-28T13:57:37+00:00","mainEntityOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/conference-online-antibioresistance-mecanismes-et-innovation-therapeutique-12-et-13-juillet-2021\/"},"wordCount":276,"publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/conference-online-antibioresistance-mecanismes-et-innovation-therapeutique-12-et-13-juillet-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/06\/Webconf-antibios3.jpg","articleSection":["Actualit\u00e9s","Ev\u00e8nements & Colloques"],"inLanguage":"fr-FR"},{"@type":["WebPage","ItemPage"],"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/conference-online-antibioresistance-mecanismes-et-innovation-therapeutique-12-et-13-juillet-2021\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/conference-online-antibioresistance-mecanismes-et-innovation-therapeutique-12-et-13-juillet-2021\/","name":"Conf\u00e9rence online : \"Antibior\u00e9sistance : m\u00e9canismes et innovation th\u00e9rapeutique\", 12 et 13 juillet 2021 - Interface nationale ANTIBIOR\u00c9SISTANCE","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/conference-online-antibioresistance-mecanismes-et-innovation-therapeutique-12-et-13-juillet-2021\/#primaryimage"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/conference-online-antibioresistance-mecanismes-et-innovation-therapeutique-12-et-13-juillet-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/06\/Webconf-antibios3.jpg","datePublished":"2021-06-28T11:20:15+00:00","dateModified":"2021-06-28T13:57:37+00:00","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","breadcrumb":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/conference-online-antibioresistance-mecanismes-et-innovation-therapeutique-12-et-13-juillet-2021\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/conference-online-antibioresistance-mecanismes-et-innovation-therapeutique-12-et-13-juillet-2021\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/conference-online-antibioresistance-mecanismes-et-innovation-therapeutique-12-et-13-juillet-2021\/#primaryimage","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/06\/Webconf-antibios3.jpg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/06\/Webconf-antibios3.jpg","width":748,"height":345,"caption":"Cr\u00e9dit : Aviesan"},{"@type":"BreadcrumbList","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/conference-online-antibioresistance-mecanismes-et-innovation-therapeutique-12-et-13-juillet-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/"},{"@type":"ListItem","position":2,"name":"Infos pratiques & communications","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/"},{"@type":"ListItem","position":3,"name":"Actualit\u00e9s","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/"},{"@type":"ListItem","position":4,"name":"Conf\u00e9rence online : “Antibior\u00e9sistance : m\u00e9canismes et innovation th\u00e9rapeutique”, 12 et 13 juillet 2021"}]},{"@type":"WebSite","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/","name":"Interface nationale ANTIBIOR\u00c9SISTANCE","description":"PPR Antibior\u00e9sistance - Inserm","publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization","name":"Inserm","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","width":1,"height":1,"caption":"Inserm"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3","name":"\u00c9milie Noguez"}]}},"publishpress_future_action":{"enabled":false,"date":"2026-04-24 04:41:16","action":"change-status","newStatus":"private","terms":[],"taxonomy":"category"},"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/14225"}],"collection":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/users\/139"}],"replies":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/comments?post=14225"}],"version-history":[{"count":10,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/14225\/revisions"}],"predecessor-version":[{"id":14253,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/14225\/revisions\/14253"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/media\/14255"}],"wp:attachment":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/media?parent=14225"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/categories?post=14225"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/tags?post=14225"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}